- Home
- DTSS vs BGLC Comparison
DTSS vs BGLC Comparison
Compare DTSS & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTSS
- BGLC
- Stock Information
- Founded
- DTSS 2014
- BGLC 2017
- Country
- DTSS China
- BGLC Malaysia
- Employees
- DTSS N/A
- BGLC N/A
- Industry
- DTSS Computer Software: Prepackaged Software
- BGLC Medical Specialities
- Sector
- DTSS Technology
- BGLC Health Care
- Exchange
- DTSS Nasdaq
- BGLC Nasdaq
- Market Cap
- DTSS 10.3M
- BGLC 7.6M
- IPO Year
- DTSS N/A
- BGLC N/A
- Fundamental
- Price
- DTSS $2.38
- BGLC $0.37
- Analyst Decision
- DTSS
- BGLC
- Analyst Count
- DTSS 0
- BGLC 0
- Target Price
- DTSS N/A
- BGLC N/A
- AVG Volume (30 Days)
- DTSS 941.0K
- BGLC 117.9K
- Earning Date
- DTSS 11-11-2024
- BGLC 11-20-2024
- Dividend Yield
- DTSS N/A
- BGLC N/A
- EPS Growth
- DTSS N/A
- BGLC N/A
- EPS
- DTSS N/A
- BGLC N/A
- Revenue
- DTSS $23,975,867.00
- BGLC $9,183,168.00
- Revenue This Year
- DTSS N/A
- BGLC N/A
- Revenue Next Year
- DTSS N/A
- BGLC N/A
- P/E Ratio
- DTSS N/A
- BGLC N/A
- Revenue Growth
- DTSS 558.55
- BGLC N/A
- 52 Week Low
- DTSS $1.42
- BGLC $0.31
- 52 Week High
- DTSS $20.29
- BGLC $3.39
- Technical
- Relative Strength Index (RSI)
- DTSS 54.30
- BGLC 32.80
- Support Level
- DTSS $2.10
- BGLC $0.38
- Resistance Level
- DTSS $2.49
- BGLC $0.49
- Average True Range (ATR)
- DTSS 0.23
- BGLC 0.02
- MACD
- DTSS 0.00
- BGLC -0.01
- Stochastic Oscillator
- DTSS 40.00
- BGLC 5.94
About DTSS Datasea Inc.
Datasea Inc is a development stage company engaged in Internet security products. Its offers service and products such as Internet Security Equipment, New Media Advertising Service, Micro Marketing Service, Internet Service Provider (ISP) Connecting Service, Big Data Processing Service. The business activity of the group functions through China.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.